Medfinder
Back to blog

Updated: January 15, 2026

Why Is Humalog So Hard to Find? [Explained for 2026]

Author

Peter Daggett

Peter Daggett

Empty pharmacy shelf with scattered medication bottles and a magnifying glass search icon

Humalog (insulin lispro) has been hard to find at some pharmacies. Here's why shortages happen and what you can do to get your prescription filled in 2026.

If you have diabetes and rely on Humalog (insulin lispro) to manage your blood sugar around meals, discovering that your pharmacy is out of stock can feel alarming — and for good reason. Insulin isn't something you can skip. So why does Humalog go out of stock, and what can you do about it in 2026?

In this guide, we break down the reasons behind Humalog availability issues, what happened during the 2024 shortage, and the practical steps you can take right now to find your medication.

What Is Humalog and Why Do So Many People Need It?

Humalog is a brand-name rapid-acting insulin analog made by Eli Lilly and Company. Its active ingredient is insulin lispro — a slightly modified version of human insulin that works faster than regular insulin. It starts lowering blood sugar within about 15 minutes, peaks at roughly 1 hour, and lasts 2 to 4 hours.

Humalog is used by millions of Americans — both those with Type 1 diabetes (who can't produce any insulin at all) and those with Type 2 diabetes who need mealtime insulin to cover blood sugar spikes after eating. Because it's a life-sustaining medication taken multiple times a day, even a short supply disruption can put patients in a dangerous situation.

What Caused the 2024 Humalog Shortage?

In early 2024, Eli Lilly publicly acknowledged a shortage of Humalog and generic insulin lispro vials. The company attributed the shortage to what a spokesperson called "the dynamic nature of insulin supply and demand, coupled with brief delays in manufacturing."

Specifically, Eli Lilly discontinued the smaller 3 mL vials of Humalog and insulin lispro. This was significant because many patients — particularly those who used smaller doses or who preferred smaller vials — had no direct replacement. The 10 mL vials and prefilled KwikPen versions continued to be manufactured and, by late 2024 and into 2025, were back in broader circulation.

But the damage was done: patients and pharmacies had been caught off guard, and trust in consistent supply had taken a hit.

Why Does Insulin Get Harder to Find — Even Without a Formal Shortage?

Even when there's no official shortage on record, Humalog and other insulins can be difficult to find at specific pharmacies for a handful of reasons:

[@portabletext/react] Unknown block type "block", specify a component for it in the `components.types` prop
  • Localized stockouts at pharmacies. National supply can be healthy while individual pharmacies — especially independent ones or those in rural areas — run short due to ordering cycles or distribution delays.
  • Insurance formulary changes. Some insurance plans moved patients to preferred-tier alternatives like Admelog or generic insulin lispro. When plans shift, patients and pharmacies both scramble.
  • Discontinued product forms. After Lilly discontinued the 3 mL vials in 2024, patients who depended on that specific form needed to adapt to 10 mL vials or pens.
  • Competition from GLP-1 drugs. As manufacturers like Eli Lilly have shifted production resources toward high-demand GLP-1 drugs (like Mounjaro and Zepbound), some insulin production capacity has been reallocated.

Is Humalog in Shortage Right Now in 2026?

As of 2026, Humalog is not listed as an active nationwide shortage by the FDA or ASHP. The national supply of Humalog 10 mL vials and KwikPens has largely stabilized since the 2024 disruptions. However, localized stockouts at specific pharmacies are still reported, and the 3 mL vial format remains discontinued.

The bottom line: Humalog is generally available in 2026, but you may not be able to fill your prescription at the first pharmacy you call. That's where having a strategy matters.

What Can You Do If You Can't Find Humalog?

Here are the most effective steps if you're running into availability issues:

  1. Call multiple pharmacies. Stock varies widely even between pharmacies in the same neighborhood. Independent pharmacies sometimes have stock when chains don't.
  2. Use medfinder. medfinder calls pharmacies near you to check which ones have Humalog in stock and can fill your specific prescription — saving you hours of phone time.
  3. Ask about generic insulin lispro. Insulin lispro is the authorized generic version of Humalog — same molecule, made by Lilly's subsidiary. It's available as a 10 mL vial for as little as $25 and may have better stock than brand-name Humalog at some pharmacies.
  4. Talk to your doctor about alternatives. If Humalog is unavailable, your doctor can prescribe an equivalent rapid-acting insulin such as Admelog (insulin lispro, Sanofi), NovoLog (insulin aspart), or Apidra (insulin glulisine). Most require no dose adjustment.
  5. Try mail-order pharmacy. Mail-order pharmacies often have more reliable insulin stock than retail locations. Check with your insurance about mail-order benefits for 90-day supplies.
  6. Order refills early. Don't wait until you're completely out. Request your refill as soon as your insurance allows (typically when you have 7–10 days of supply remaining).

What About Price — Is Cost Making Humalog Hard to Access?

Cost has historically been a barrier to insulin access. In March 2023, Eli Lilly cut Humalog's list price by 70% and capped out-of-pocket costs at $35 per month through the Lilly Insulin Value Program. Today, a 10 mL vial of Humalog runs between $72 and $86 at list price, while the authorized generic insulin lispro vial has a list price of just $25.

For Medicare patients, the Inflation Reduction Act capped insulin costs at $35 per month under Part D. Uninsured patients who qualify can receive free insulin through the Lilly Cares Foundation Patient Assistance Program (LillyCares.com, 1-800-545-6962) for patients at or below 400% of the federal poverty level.

The Bigger Picture: Why Insulin Supply Is a Systemic Problem

The insulin market is unusual. A handful of companies supply life-sustaining medications to tens of millions of patients who have no alternative. When manufacturing hiccups occur, the consequences can be severe. The 2024 Humalog shortage highlighted how fragile insulin supply chains can be — and why patients need strategies for navigating them.

Being proactive — knowing your alternatives, keeping a small supply buffer, and having a plan to locate stock quickly — is the best defense against a future disruption.

How medfinder Can Help You Find Humalog

Searching for Humalog at pharmacy after pharmacy wastes valuable time. medfinder is a service that calls pharmacies near you to find out which ones have Humalog — or its generic equivalents — in stock and ready to fill your specific prescription. You provide your medication, dosage, and location; medfinder does the calling; and you get results texted directly to you. For more tips on locating Humalog quickly, see our guide on how to find Humalog in stock near you.

Frequently Asked Questions

Humalog is not listed as an active nationwide shortage by the FDA or ASHP in 2026. The national supply of Humalog 10 mL vials and KwikPens has largely stabilized. However, the 3 mL vials were permanently discontinued in 2024, and some local pharmacies may still experience temporary stockouts. Calling ahead or using medfinder can help you locate available stock quickly.

In 2024, Eli Lilly discontinued the smaller 3 mL vials of Humalog and generic insulin lispro, citing manufacturing supply and demand dynamics. The company has continued producing the 10 mL vials and all KwikPen formats. Patients who depended on the 3 mL vials typically need to transition to the 10 mL vial or a prefilled pen.

Several rapid-acting insulin alternatives can be substituted for Humalog with your doctor's guidance. These include Admelog (insulin lispro by Sanofi), NovoLog or Fiasp (insulin aspart by Novo Nordisk), Apidra (insulin glulisine by Sanofi), and Lyumjev (insulin lispro-aabc by Lilly). Most switches require no dose change, but always consult your provider before switching insulins.

After Eli Lilly's 70% list price reduction in 2023, Humalog 10 mL vials now list for approximately $72–$86. The authorized generic insulin lispro vial lists at just $25. The Lilly Insulin Value Program caps out-of-pocket costs at $35 per month regardless of insurance. Medicare Part D patients pay no more than $35 per month under the Inflation Reduction Act.

National supply and local pharmacy stock are two different things. Even when Humalog supply is healthy nationally, individual pharmacies can run out due to ordering cycles, distribution delays, or formulary changes. Independent and smaller pharmacies are especially susceptible to temporary stockouts. Checking multiple pharmacies or using a service like medfinder can help you find available stock quickly.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Humalog also looked for:

Admelog (insulin lispro, Sanofi)NovoLog / Fiasp (insulin aspart, Novo Nordisk)Apidra (insulin glulisine, Sanofi)Lyumjev (insulin lispro-aabc, Eli Lilly)

30,033 have already found their meds with Medfinder.

Start your search today.

30K+
5-star ratingTrusted by 30,033 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?